Physician profile
Patrick Griffith
NPI 1194828301
$3,292.26
in general payments reported to CMS, 2019-2025
20 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $176 · 2021: $712 · 2022: $835 · 2023: $654 · 2024: $423 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,267.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $861.15 | 2021-2025 | |
| Pfizer INC. | $558.96 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $399.70 | 2021-2025 | Trintellix |
| Novo Nordisk INC | $288.20 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.65 | 2022-2023 | Jardiance |
| Lilly USA, LLC | $226.65 | 2021-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $167.97 | 2021-2023 | |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $60.61 | 2022 | |
| Esperion Therapeutics, INC. | $58.81 | 2022-2024 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $57.58 | 2023 | |
| Abbott Laboratories | $53.98 | 2021-2023 | Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $45.23 | 2023 | Gemtesa |
| Sunovion Pharmaceuticals INC. | $41.62 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $34.43 | 2023 | Quviviq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $33.28 | 2021-2022 | |
| Biogen, INC. | $23.66 | 2021 | |
| Glaxosmithkline, LLC. | $19.60 | 2021 | |
| Exact Sciences Corporation | $16.66 | 2025 | The Cologuard Plus Collection Kit |
| Tolmar, INC. | $13.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.